Cel-Sci (CVM) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Instil Bio (TIL) has outperformed Cel-Sci (CVM) over the past year, losing 68.0% versus a loss of 80.6%. Over five years, TIL leads with a -98.2% price change compared with -99.4% for CVM. Instil Bio is the larger company by market cap ($44.5 million vs $34.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVM | TIL |
|---|---|---|
| Share price | $1.95 | $6.56 |
| Market cap | $34.30M | $44.49M |
| 1-day change | -8.45% | -4.23% |
| YTD return | -62.93% | -40.36% |
| 1-year return | -80.56% | -68.05% |
| 5-year return | -99.38% | -98.17% |
| EPS (TTM) | $-1.69 | $-4.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.39 | $21.98 |
| 52-week low | $0.89 | $5.67 |
| Distance from 52-week high | -81.23% | -70.15% |
| Analyst consensus | none | none |
| Avg. price target upside | +541.03% | +6.71% |
| Average volume | 241.50K | 12.54K |
| Shares outstanding | 17.59M | 6.78M |
| Employees | — | 17 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TIL has outperformed CVM by 12.5 percentage points over the past year.
About Cel-Sci
CVM stock →CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers.
Healthcare · Biotechnology
About Instil Bio
TIL stock →Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Healthcare · Biotechnology · 17 employees
CVM vs TIL FAQ
Which is bigger, Cel-Sci or Instil Bio?
Instil Bio (TIL) is larger, with a market capitalization of $44.49M compared with $34.30M for Cel-Sci (CVM).
Which stock has performed better over the past year, CVM or TIL?
TIL returned -68.05% over the past 12 months, compared with -80.56% for CVM (price return, excluding dividends). Past performance does not predict future results.
Are Cel-Sci and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.